Related Experiment Video
Updated: Jul 14, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
[Bioinformatics scan analysis for predicting drug targeted modulation on ID4 gene expression]
Xue-Chun Lu1, Xiao-Hua Chi, Fang-Ding Lou
1Department of Geriatric Hematology, Department of Hematolody, PLA General Hospital, Beijing 100853, China.
Abstract:
Low expression of ID4 gene is tightly related with carcinogenesis and high expression shows a definite anti-leukemia effect, though little expression in some leukemia cells. The main purpose of this preliminary work was to analyze the construction of ID4 gene promoter and to predict the cis elements in the ID4 promoter region by scanning the drug candidate with bioinformatics method. All these work are the primary part for finding effective drugs in the treatment of leukemia via the way of ID4 expression regulation. According to the data in GenBank and Internet platform, the 5'-untranslated sequence just upstream of ID4 ORF was virtually cloned. TESS, Genomatix and GenBank databank were used to analyze the cis elements in this area. RSA was used to find the distribution patterns for all these possible elements. SAGE and GEO datasets were used to find active substances which have the effect on the ID4 expression. The rsults indicated that ID4 had a type II promoter with a typical TATA box-45 bp upstream the transcriptional original site. There were a lot of various cis elements in the 5'-untranslated region upstream, including both positive element candidates such as Sp1, c-Myb, abaA, GR, ER, Zeste and C/EBPalpha and negative element candidates such as CCAAT-binding factor, GCF, WT1-KTS, HiNF-C and EGR2. It is concluded that estrogen, dexamethasone, thyroid hormone and follicle stimulating hormone may participate in the regulation of ID4 gene expression in both positive and negative manners.
Insights
Investigating the ID4 gene promoter revealed potential drug targets for leukemia treatment. Identifying cis-acting elements and regulatory factors provides a foundation for developing novel ID4 expression-modulating therapies.
Area of Science:
- Genetics and Molecular Biology
- Bioinformatics
- Cancer Research
Context:
- The ID4 gene's expression levels are linked to cancer development and leukemia progression.
- Understanding ID4 gene regulation is crucial for developing targeted leukemia therapies.
Purpose:
- To analyze the ID4 gene promoter structure and predict cis-acting elements using bioinformatics.
- To identify potential drug candidates that modulate ID4 expression for leukemia treatment.
Summary:
- Bioinformatic analysis of the ID4 5'-untranslated region identified a Type II promoter with a TATA box.
- Numerous positive (Sp1, c-Myb, GR, ER) and negative (CCAAT-binding factor, WT1-KTS) cis-acting elements were predicted.
- Hormones like estrogen, dexamethasone, and thyroid hormone may regulate ID4 expression.
Impact:
- This study provides a foundational understanding of ID4 gene regulation.
- Identified cis-elements and potential regulatory factors serve as targets for novel leukemia therapies.
- The findings pave the way for developing drugs that leverage ID4 expression for anti-leukemia effects.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
